0000950170-23-060499.txt : 20231107
0000950170-23-060499.hdr.sgml : 20231107
20231107181954
ACCESSION NUMBER: 0000950170-23-060499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231106
FILED AS OF DATE: 20231107
DATE AS OF CHANGE: 20231107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: de los Pinos Elisabet
CENTRAL INDEX KEY: 0001889633
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40971
FILM NUMBER: 231385428
MAIL ADDRESS:
STREET 1: C/O AURA BIOSCIENCES, INC.
STREET 2: 85 BOLTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aura Biosciences, Inc.
CENTRAL INDEX KEY: 0001501796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 320271970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
BUSINESS PHONE: (617)500-8864
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 01235
4
1
ownership.xml
4
X0508
4
2023-11-06
0001501796
Aura Biosciences, Inc.
AURA
0001889633
de los Pinos Elisabet
C/O AURA BIOSCIENCES, INC.
80 GUEST STREET
BOSTON
MA
01235
true
true
false
false
See Remarks
true
Common Stock
2023-11-06
4
M
false
3800
2.74
A
184740
D
Common Stock
2023-11-06
4
S
false
7449
12.0299
D
177291
D
Common Stock
131412
I
By EdIP Revocable Trust
Stock Option (Right to Buy)
2.74
2023-11-06
4
M
false
3800
0.00
D
2028-02-21
Common Stock
3800
361163
D
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held by the Elisabet de los Pinos Revocable Trust U/D/T dated April 8, 2016, of which the Reporting Person is a trustee.
This option is fully vested.
President and Chief Executive Officer
/s/ Julie Feder, as Attorney-in-Fact
2023-11-07